在癌症和药物发现中铁亡的最近进展
Xiang Wang1, Xinxin Ren2,3,4, Xu Lin5
1Department of Pharmacy, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China.
Asian journal of pharmaceutical sciences
|September 9, 2024
概括
铁,一种依赖于铁的细胞死亡,抑制了癌症的扩散. 用像埃拉斯这样的诱导剂向铁亡,可以与抗癌药物产生协同效应,从而改善患者的预后.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 铁亡是一种受调节的细胞死亡形式,依赖于铁和脂质过氧化.
- 这种细胞死亡途径与各种疾病有关,尤其是癌症.
- 铁灭酶在抑制瘤细胞生长方面发挥着至关重要的作用.
研究的目的:
- 阐明铁灭的分子机制和特征.
- 审查铁化在癌症发展和治疗策略中的多方面的作用.
- 探索铁灭菌在癌症预后预测和新药发现方面的潜力.
主要方法:
- 关于铁灭症研究的文献综述.
- 对涉及铁灭诱导的分子通路的分析.
- 检查对铁灭诱导剂及其组合疗法的研究.
主要成果:
- 铁灭诱导有效地抑制了癌细胞的增殖.
- 小分子铁灭诱导剂 (例如,埃拉斯,RSL3,FIN56) 显示出有希望的结果.
- 与铁致死诱导剂和抗癌药物的联合治疗产生了协同效应,改善了患者的治疗结果.
结论:
- 了解铁亡对于推进癌症治疗至关重要.
- 向铁灭症为新型癌症疗法和药物开发提供了一个有希望的途径.
- 铁亡调节具有预测患者预后的潜力.
更多相关视频
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K